Alex Therapeutics is a digital health company that focuses on developing evidence-based companion apps designed to assist patients in managing their medications and mental health challenges, particularly in the context of complex treatment regimens associated with cancer and rare diseases. Their approach emphasizes a comprehensive strategy that goes beyond simple medication reminders, integrating artificial intelligence to help patients understand the relationship between their symptoms and medications. This customization allows the apps to cater to various patient populations and treatment needs, ultimately aiming to empower patients to adhere to their treatment plans effectively.

The company has also made significant strides in the development of Software as a Medical Device (SaMD) products, which have demonstrated clinically and statistically significant benefits across a range of health conditions. Notably, Alex Therapeutics has partnered with Navamedic to create a companion app specifically for Parkinson’s disease, which will provide tailored medication management support. This collaboration highlights their commitment to enhancing patient care through innovative digital solutions, with plans for the app's launch in Nordic countries and potential global expansion.

Sweden

At Alex Therapeutics we provide digital health solutions that enable pharmaceutical companies to better support their products, and their patients.

Leveraging our proven modular technology platform allows partners to reduce time-to-market and enables frictionless deployment of safe, secure and effective  digital health products.

Over 100,000 patients have used our products globally, with our best-in-class user experience design ensuring better health engagement and outcomes.

Alex Therapeutics

Company Details